ArticleJournal of human hypertension2025
Age- and sex-specific reference intervals for renin and aldosterone in healthy individuals in Yunnan Province, China.
Article in Journal of human hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Measurements of renin and aldosterone are important for the diagnosis and treatment of different renin sub-types of hypertension as well as endocrine hypertension, particularly primary aldosteronism (PA). However, numerous factors can influence the measurements of renin and aldosterone, including geographical location, ethnicity, body posture, dietary habits, sex, and age, instrumentation, methodology. This study aimed to establish age- and sex-specific reference intervals for renin and aldosterone in Yunnan Province, China. This study was a cross-sectional survey conducted in Yunnan Province, China, using multi-stage stratified random sampling method from four districts/counties and urban and rural settings. Age, gender, medical history, medication history and family history of the individuals were first collected, then height, weight, blood pressure and heart rate were measured and blood specimens were collected to test biochemical parameters, plasma renin concentration (PRC) and plasma aldosterone concentration (PAC). During the selection process, we first excluded individuals with obvious clinical symptoms and diagnosed diseases, and selected 9129 ostensibly healthy as the initial sample. Next, we excluded participants who were in pregnancy, lactating, taking contraceptive, hypertension, hypokalemia, renal insufficiency, obesity, and finally successfully included 5200 individuals. A rigorous statistical analysis was conducted to investigate differences in renin and aldosterone levels by sex and age, facilitating the redefinition of groups, and subsequently, reference intervals for renin and aldosterone were established within the redefined groups. Renin and aldosterone levels differed significantly across sex and age groups. Specifically, PRC was significantly lower in women than men, while PAC was significantly higher in men than women. PRC decreased with age, while PAC levels were lowest in the 18-24 age group and peaked in the 25-64 age group. Our findings underscore the crucial role of sex and age when precisely evaluating renin and aldosterone levels. This study established, for the first time, age- and sex-specific reference intervals for renin and aldosterone in healthy individuals in Yunnan Province, China. These findings may provide some guidance for the diagnosis and treatment of different renin sub-types of hypertension, as well as some help in providing new ideas for further research on PA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.